AWM
ANRO icon

Avior Wealth Management’s Alto Neuroscience ANRO Stock Holding History

Avior Wealth Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-249
Closed -$1.05K – 2399
2024
Q4 		$1.05K Buy
249
+48
+24% +$300 ﹤0.01% 2197
2024
Q3 		$2.3K Sell
201
-35
-15% -$428 ﹤0.01% 1957
2024
Q2 		$2.52K Buy
+236
New +$3.07K ﹤0.01% 1898

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Avior Wealth Management's ANRO Position: Q1 2025 in Review

Avior Wealth Management sold out of Alto Neuroscience (ANRO) in Q1 2025, closing a stake of 249 shares — an estimated $1.05K sold.

Avior Wealth Management first reported a position in ANRO in Q2 2024 and held it in 3 quarters. The position peaked at $2.52K in Q2 2024. 83 funds tracked by Wall St. Rank hold ANRO as of Q1 2025.

  • Avior Wealth Management reported no remaining Alto Neuroscience position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 249 Alto Neuroscience shares in Q1 2025, an estimated $1.05K.
  • Avior Wealth Management first reported a position in Alto Neuroscience in Q2 2024 and held it in 3 quarters.
  • Avior Wealth Management's Alto Neuroscience position peaked at $2.52K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.